Professor Peter Johnson is the director of the Southampton Cancer Research UK Centre. He is a leading expert in lymphoma, a cancer that affects the body’s disease-fighting white blood cells.

Professor Johnson recently led a clinical trial for patients with advanced Hodgkin lymphoma. He was looking at how a sophisticated type of imaging early on during treatment could help predict how well tumours were responding to chemotherapy. The findings will allow doctors to tailor treatment to each individual patient, meaning better outcomes and fewer side effects.